Special Issues



More for You

2019 Compendium of Federal Medicine

Medication-Assisted Therapy Provided to Few Veterans with Opioid Use Disorders

Medication-assisted therapy has been underused at the VA, especially for patients with opioid use disorders, according to recent research. That is likely to change, however, with powerful support for expansion of those programs and more... View Article

2019 Compendium of Federal Medicine

VA Continues to Grapple with Reducing Mortality, Disability in MS Patients

A new study looks at factors to improve survival rates in veterans with multiple sclerosis. VA’s efforts don’t stop there, however. The healthcare system has a multipronged effort to reduce disability and improve quality of... View Article

2019 Compendium of Federal Medicine

FDA Uses Speedy New Process to Approve First Drug for Newly Diagnosed PTCL

Until last fall, no established standard of care existed for newly diagnosed peripheral T-cell lymphoma. But, using a new process, the Food and Drug Administration agreed to expand the indications for brentuximab vedotin only two... View Article

2019 Compendium of Federal Medicine

Incidence of Nonalcoholic Fatty Liver Disease Rises Quickly in U.S. Military

NASLD Is A Leading Risk Factor for Hepatocellular Carcinoma Over the last 17 years, the incidence of nonalcoholic fatty liver disease among active-duty U.S. military servicemembers leapt from 12.6 cases per 100,000 person-years to 152.8.... View Article

2019 Compendium of Federal Medicine

Treating Type 2 Diabetes to Improve Cardiovascular Health

Because of their cardiovascular protective effects, SGLT2 inhibitors have been a game-changer in Type 2 diabetes treatment. That is especially the case, now that the FDA has approved a new indication for canagliflozin to reduce... View Article

2019 Compendium of Federal Medicine

Technology Intervention Improves Continuity of Care for VA Schizophrenia Patients

An estimated 4% of veterans in care at the VA have a diagnosis of schizophrenia, and they are among the greatest users of healthcare resources. That’s why VA is piloting innovative programs to provide continuity... View Article

2019 Compendium of Federal Medicine

While Screening More for Lung Cancer, VA Grapples with Getting Veterans to Follow Up

With veterans at generally higher risk of lung cancer for a variety of reasons, the VA is seeking to catch cases earlier by instituting widespread screening. The healthcare system is facing a difficult challenge, however:... View Article

2019 Compendium of Federal Medicine

Nontuberculous Mycobacteria Infections On the Increase in VA’s COPD Patients

Inhaled Steroids a Factor Veterans with COPD have been hit hard by an increase in nontuberculous mycobacteria infections. Researchers suggest that treatment with inhaled steroids appears to play a role in the rising rates, but... View Article

2019 Compendium of Federal Medicine

DHA Considers Expanding Continuous Glucose Monitoring Coverage to Type 2 Diabetes

Results of a range of studies are conclusive: Continuous glucose monitoring can improve glycemic control and reduce hypoglycemia risks in patients with both Type 1 and Type 2 diabetes. Now, the Defense Health Agency, which... View Article

Meeting the Challenges of Hepatocellular Carcinoma in Federal Medicine

VA Continues to Improve Management of Deadly Hepatocellular Carcinoma

WASHINGTON—With the number of veterans being diagnosed with hepatocellular carcinoma continuing to rise, the VA has implemented several new initiatives to improve outcomes for patients with this aggressive cancer. The most common type of liver... View Article

Meeting the Challenges of Hepatocellular Carcinoma in Federal Medicine

Rising Rates of Nonalcoholic Fatty Liver Disease Drive Up Hepatocellular Carcinoma Cases

HOUSTON—A new epidemic appears poised to overtake hepatitis C as the leading cause of hepatocellular carcinoma. “Nonalcoholic fatty liver disease is the next big thing in the epidemiology of liver cancer,” said Fasiha Kanwal, MD,... View Article

Meeting the Challenges of Hepatocellular Carcinoma in Federal Medicine

HCC Risk Remains for Some, Even After Hepatitis C is Cured

HOUSTON—The VA has announced that it expects to eliminate hepatitis C in all veterans willing and able to receive treatment by May of this year. Successful treatment for HCV also dramatically reduces the risk of... View Article

Meeting the Challenges of Hepatocellular Carcinoma in Federal Medicine

Federal Medicine Clinicians Now Have Many More Treatment Options for HCC

RICHMOND, VA—For more than a decade after the U.S. Food and Drug Administration approved sorafenib for hepatocellular cancer, treatment options for the aggressive malignancy remained static. That changed dramatically in the last 24 months as... View Article